Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

Phase 3RecruitingNCT04168099

Tanta University60 enrolled

Overview

oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis

Comparative Study between the Efficacy of oral Gemifloxacin and intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Cefotaxime IV

Gemifloxacin oral

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with spontaneous bacterial peritonitis Exclusion Criteria: * secondary peritonitis

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Number of patients with resolution of infection

the total number of patients with resolution of infection

Time frame: 6 months

Sherief Abd-Elsalam, ass. prof.

CONTACT

sherief abd-elsalam, ass. prof.

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.